Literature DB >> 20566365

Proteomic analysis of two Trypanosoma cruzi zymodeme 3 strains.

Simone A Kikuchi1, Cátia L Sodré, Dário E Kalume, Camila G R Elias, André L S Santos, Maria de Nazaré Soeiro, Marcus Meuser, Alex Chapeaurouge, Jonas Perales, Octavio Fernandes.   

Abstract

Two Trypanosoma cruzi Z3 strains, designated as 3663 and 4167, were previously isolated from insect vectors captured in the Brazilian Amazon region. These strains exhibited different infection patterns in Vero, C6/36, RAW 264.7 and HEp-2 cell lineages, in which 3663 trypomastigote form was much less infective than 4167 ones. A proteomic approach was applied to investigate the differences in the global patterns of protein expression in these two Z3 strains. Two-dimensional (2D) protein maps were generated and certain spots were identified by mass spectrometry (MS). Our analyses revealed a significant difference in the expression profile of different proteins between strains 3663 and 4167. Among them, cruzipain, an important regulator of infectivity. This data was corroborated by flow cytometry analysis using anti-cruzipain antibody. This difference could contribute to the infectivity profiles observed for each strain by in vitro assay using different cell lines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566365     DOI: 10.1016/j.exppara.2010.06.005

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  4 in total

1.  Multiple effects of pepstatin A on Trypanosoma cruzi epimastigote forms.

Authors:  Leandro S Sangenito; Keyla C Gonçalves; Erika A Abi-Chacra; Cátia L Sodré; Claudia M d'Avila-Levy; Marta H Branquinha; André L S Santos
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

2.  Repertoire, genealogy and genomic organization of cruzipain and homologous genes in Trypanosoma cruzi, T. cruzi-like and other trypanosome species.

Authors:  Luciana Lima; Paola A Ortiz; Flávia Maia da Silva; João Marcelo P Alves; Myrna G Serrano; Alane P Cortez; Silvia C Alfieri; Gregory A Buck; Marta M G Teixeira
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

Review 3.  Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.

Authors:  L O Santos; A S Garcia-Gomes; M Catanho; C L Sodre; A L S Santos; M H Branquinha; C M d'Avila-Levy
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 4.  Defeating the trypanosomatid trio: proteomics of the protozoan parasites causing neglected tropical diseases.

Authors:  Anutthaman Parthasarathy; Karunakaran Kalesh
Journal:  RSC Med Chem       Date:  2020-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.